Kerusso Capital Management LLC Acquires New Position in The Clorox Company (NYSE:CLX)

Kerusso Capital Management LLC bought a new position in The Clorox Company (NYSE:CLX) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 17,863 shares of the company’s stock, valued at approximately $2,438,000.

A number of other institutional investors have also modified their holdings of CLX. Loudon Investment Management LLC increased its stake in shares of Clorox by 7.6% during the second quarter. Loudon Investment Management LLC now owns 5,732 shares of the company’s stock valued at $782,000 after buying an additional 405 shares during the period. Mine & Arao Wealth Creation & Management LLC. grew its holdings in Clorox by 2.8% during the 2nd quarter. Mine & Arao Wealth Creation & Management LLC. now owns 3,403 shares of the company’s stock worth $464,000 after acquiring an additional 94 shares in the last quarter. Cullen Frost Bankers Inc. increased its position in Clorox by 1,790.4% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 40,512 shares of the company’s stock valued at $5,529,000 after purchasing an additional 38,369 shares during the period. Lake Street Advisors Group LLC raised its holdings in shares of Clorox by 7.0% in the 2nd quarter. Lake Street Advisors Group LLC now owns 1,747 shares of the company’s stock valued at $238,000 after purchasing an additional 115 shares in the last quarter. Finally, Advisor OS LLC lifted its position in shares of Clorox by 48.1% in the 2nd quarter. Advisor OS LLC now owns 4,594 shares of the company’s stock worth $627,000 after purchasing an additional 1,493 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

NYSE CLX opened at $164.75 on Friday. The stock’s fifty day moving average price is $142.93 and its 200 day moving average price is $142.85. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $166.49. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The company has a market cap of $20.46 billion, a price-to-earnings ratio of 85.36, a PEG ratio of 3.21 and a beta of 0.40.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. As a group, equities research analysts forecast that The Clorox Company will post 6.56 earnings per share for the current year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were issued a $1.22 dividend. This is an increase from Clorox’s previous quarterly dividend of $1.20. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date was Tuesday, August 13th. Clorox’s dividend payout ratio is 252.85%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Argus raised shares of Clorox to a “hold” rating in a research note on Tuesday, June 4th. JPMorgan Chase & Co. decreased their price objective on Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. Barclays raised their price objective on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Citigroup raised their price target on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday. Six equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $143.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.